Government urged to scrap drug-pricing system in controversy

Korea’s pharmaceutical companies are revealing a high-pitched voice over the current cash reward system for doctors and pharmacists, calling for the government to scrap the regulation.

They claimed that if the regulation exists, escalating price competition would damage the profitability of drug firms and reduce their investment in research and development (R&D) to make new products and qual...